Neurotez, Inc.

11/20/2025

https://www.linkedin.com/feed/update/urn:li:activity:7396916946669109248/

We are pleased to welcome Nikolaos Tezapsidis, President & CEO of Neurotez, Inc., as the Day 2 Chairperson for the 𝟮𝟰𝘁𝗵 𝗕𝗶𝗼𝗣𝗵𝗮𝗿𝗺𝗮 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗡𝗲𝘅𝘂𝘀 𝗡𝗲𝘄 𝗝𝗲𝗿𝘀𝗲𝘆 Dr. Tezapsidis, an...

03/28/2025

https://www.facebook.com/share/p/15Cat97iK5/

Amidst the deluge of data, finding the right balance between working models and useful insights remains pivotal in forging the path towards leveraging computational success in the field of biotech and pharma.

05/18/2024

Last Tuesday's Drug Discovery Biology & Bioinformatics Strategy Meeting in Princeton buzzed with a critical discussion on financing blueprints for your next breakthrough!

VC expert Gunaretnam (Guna) Rajagopal of Samsara BioCapital, expertly guided our high-powered panel: Christopher Conway (Curia), President of Research and Development, Marcie Glicksman (EnClear Therapies), VP Biology, and myself, Nikolaos Tezapsidis (Neurotez, Inc.), President & CEO

From go-to-clinic to go-to-market and go-to-fundraising strategies, the panel dissected the pros and cons of various financing blueprints, offering invaluable insights for attendees.

Missed the session? Stay tuned for more event highlights! hashtag hashtag hashtag hashtag

02/17/2024

https://www.youtube.com/watch?v=tJfabyIVLHA&t=17s

12/16/2022

From our partners at Cytox:

Should everyone know their personal risk of developing Alzheimer's disease?

Over the last few days there have been two big stories in the news concerning Alzheimer’s disease, a devastating brain disorder that destroys memory and the ability to perform simple tasks. The first came from Thor himself, actor Chris Hemsworth, who revealed he has two copies of the APOE4 gene, w...

09/01/2022

We just launched:

Neurotez Inc. is developing a drug to treat Leptin deficiency and cognitive decline in Alzheimer’s disease patients.